BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9198176)

  • 21. Major structural defects in the antithrombin gene in four families with type I antithrombin deficiency--partial/complete deletions and rearrangement of the antithrombin gene.
    Beauchamp NJ; Makris M; Preston FE; Peake IR; Daly ME
    Thromb Haemost; 2000 May; 83(5):715-21. PubMed ID: 10823268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Congenital antithrombin III deficiency associated with pulmonary thromboembolism].
    Katayama T; Akiba Y; Nishigaki Y; Morimoto H; Yamaguchi S; Fujiuchi S; Yamazaki Y; Nakano H; Ohsaki Y; Kikuchi K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jul; 35(7):790-5. PubMed ID: 9341285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism.
    Kuhle S; Lane DA; Jochmanns K; Male C; Quehenberger P; Lechner K; Pabinger I
    Thromb Haemost; 2001 Oct; 86(4):1007-11. PubMed ID: 11686316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antithrombin deficiency due to heterozygous antithrombin gene mutation and a pedigree study].
    Ye X; Feng Y; Jin PP; Zhou XH; Ding QL; Wang XF
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):587-9. PubMed ID: 18246812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene.
    Picard V; Nowak-Göttl U; Biron-Andreani C; Fouassier M; Frere C; Goualt-Heilman M; de Maistre E; Regina S; Rugeri L; Ternisien C; Trichet C; Vergnes C; Aiach M; Alhenc-Gelas M
    Hum Mutat; 2006 Jun; 27(6):600. PubMed ID: 16705712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.
    Huntington JA; Gettins PG
    Biochemistry; 1998 Mar; 37(10):3272-7. PubMed ID: 9521646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombin: in control of coagulation.
    Quinsey NS; Greedy AL; Bottomley SP; Whisstock JC; Pike RN
    Int J Biochem Cell Biol; 2004 Mar; 36(3):386-9. PubMed ID: 14687916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The confirmation of preclinical familial antithrombin deficiency using polymorphism and specific oligonucleotide probes .
    Beresford CH; Hughes PM; Olds R
    N Z Med J; 1990 Jun; 103(892):296-8. PubMed ID: 1973278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene symbol: SERPINC1. Disease: Antithrombin deficiency. Accession #Hd0514.
    Schleithoff L; Seelig HP
    Hum Genet; 2006 Feb; 118(6):775. PubMed ID: 17297683
    [No Abstract]   [Full Text] [Related]  

  • 30. Antithrombin III molecular variants with defective binding to heparin or to serine proteases: evidence of two different abnormal patterns identified by crossed immunoelectrofocusing.
    Leone G; De Stefano V; Ferrelli R; Teofili L; Tengborn L; Vahtera E; Bizzi B
    Thromb Haemost; 1988 Aug; 60(1):8-12. PubMed ID: 3187949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity of the "classical" antithrombin III deficiency.
    Sas G; Petö I; Bánhegyi D; Blaskó G; Domján G
    Thromb Haemost; 1980 Jun; 43(2):133-6. PubMed ID: 7455972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombin gene mutation 5356-5364*delCTT with type I deficiency and early-onset thrombophilia and a brief review of the antithrombin alpha-helix D molecular pathology.
    Steiner M; Steiner B; Rolfs A; Wangnick M; Burstein C; Freund M; Schuff-Werner P
    Ann Hematol; 2005 Jan; 84(1):56-8. PubMed ID: 15309521
    [No Abstract]   [Full Text] [Related]  

  • 33. [Study on the molecular mechanism of antithrombin gene C2759T (Leu99Phe) mutation causing antithrombin deficiency].
    Fu QH; Wang WB; Ding QL; Zhou RF; Wu WM; Hu YQ; Wang XF; Yan LX; Wang ZY; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):148-51. PubMed ID: 15946526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of natural coagulation inhibitors in hemostasis.
    Brandt JT
    Clin Lab Med; 1984 Jun; 4(2):245-84. PubMed ID: 6094091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thrombosis patients with familial antithrombin-III deficiency treated with heparin and antithrombin].
    Brandt P
    Ugeskr Laeger; 1981; 143(34):2145-8. PubMed ID: 7281335
    [No Abstract]   [Full Text] [Related]  

  • 36. Antithrombin III. Key factor in extracorporeal circulation.
    Ranucci M
    Minerva Anestesiol; 2002 May; 68(5):454-7. PubMed ID: 12029263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary deficiency of protein C, protein S and antithrombin III.
    Vittore CP; Demos TC
    Can Assoc Radiol J; 1996 Aug; 47(4):251-6. PubMed ID: 8696990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of newly developed technology in blood coagulation disorders].
    Matsuo T
    Rinsho Byori; 2002 May; 50(5):506-12. PubMed ID: 12078050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombin III deficiency: clinical aspects.
    Nagy I
    Haematologia (Budap); 1984; 17(1):87-91. PubMed ID: 6724356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inherited antithrombin deficiency: a review.
    Patnaik MM; Moll S
    Haemophilia; 2008 Nov; 14(6):1229-39. PubMed ID: 19141163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.